Filing Flows › Organon (OGN) › Q2 2026
Organon (OGN) Q2 2026 earnings results (second quarter 2026)
10-Q filed Jul 31, 2026
Organon (OGN) reported revenue of $1.6B for the second quarter 2026 (Q2 2026), -2% from a year earlier and +7% from the quarter before. Operating margin was 11.7%, net earnings $108M (6.9% of revenue).
Organon, Q2 2026: revenue $1.6B (-2% year over year), operating margin 11.7%, net earnings $108M, operating cash flow $107M. The chart follows the revenue to costs, profit and cash.
| Q2 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.6B | +7% | -2% |
| Gross profit | $847M | +8% | -3% |
| Operating profit | $183M | -14% | -20% |
| Net earnings | $108M | -26% | -26% |
| Operating cash flow | $107M | -52% | -51% |
| Free cash flow | $65.0M | -65% | -64% |
What changed
Revenue was $1.6B in Q2 2026, down 2% year over year and up 7% from the previous quarter.
Gross margin was 54.4%, down 0.5 points from Q2 2025. Operating profit was $0.18B, a 11.7% margin (down 2.6 points year over year). Operating expenses grew 3% against a revenue fall of 2%. The fastest-growing cost line was Other operating costs (+44%). Net earnings were $0.11B, down 26% year over year. The effective tax rate was 41.0%.
Operating cash flow was $0.11B (down 51% year over year), 99% of net earnings. Non-cash charges added back $0.03B of depreciation and $0.03B of share-based compensation. Working capital and other items used $0.06B. Capital expenditures of $0.04B left free cash flow of $0.07B.
Questions
What was Organon's revenue in the second quarter 2026?
Organon (OGN) reported revenue of $1.6B for the second quarter 2026 (Q2 2026), -2% from a year earlier and +7% from the quarter before.
Was Organon profitable in the second quarter 2026?
Operating profit was $183M (11.7% of revenue) and net earnings $108M.
Source: Organon 10-Q on SEC EDGAR.